PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. (2015)
Attributed to:
MICA: The Newcastle Proximity Laboratory
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12885-015-1598-x
PubMed Identifier: 26311526
Publication URI: http://europepmc.org/abstract/MED/26311526
Type: Journal Article/Review
Volume: 15
Parent Publication: BMC cancer
ISSN: 1471-2407